Unrelated bone marrow transplant. use of IL2 receptor monoclonal antibody (IL2-R-Ab) in prophylaxis of GVHD. the GEGMO Group
Belanger, C.; Esperou-Bourdeau, H.; Raffoux, C.; Gluckman, E.
Bone Marrow Transplantation 7(Suppl 2): 122
1991
ISSN/ISBN: 0268-3369 PMID: 1878669 Document Number: 384877
Document emailed within 1 workday
Related Documents
Topolsky, D.; Crilley, P.; Styler, M.J.; Bulova, S.; Brodsky, I.; Marks, D.I. 1996: Unrelated donor bone marrow transplantation without T cell depletion using a chemotherapy only condition regimen. Low incidence of failed engraftment and severe acute GVHD Bone Marrow Transplantation 17(4): 549-554Bishara, A.; Amar, A.; Brautbar, C.; Condiotti, R.; Lazarovitz, V.; Nagler, A. 1995: The putative role of HLA-C recognition in graft versus host disease (GVHD) and graft rejection after unrelated bone marrow transplantation (BMT) Experimental Hematology 23(14): 1667-1675
Phillips, G.L.; Nevill, T.J.; Spinelli, J.J.; Nantel, S.H.; Klingemann, H.G.; Barnett, M.J.; Shepherd, J.D.; Chan, K.W.; Meharchand, J.M.; Sutherland, H.J. 1995: Prophylaxis for acute graft-versus-host disease following unrelated donor bone marrow transplantation Bone Marrow Transplantation 15(2): 213-219
Noreen, H.J.; Davidson, M.L.; McCullough, J.; Bach, F.H.; Segall, M. 1989: HLA class Ii typing by restriction fragment length polymorphism (RFLP) in unrelated bone marrow transplant patients Transplantation Proceedings 21(1 Part 3): 2968-2970
Hassan, H.T.; Krog, C.; Stockschläder, M.; Schleimer, B.; Zeller, W.; Krüger, W.; Erttmann, R.; Zander, A.R. 1997: Factors influencing the haematological recovery after allogeneic bone marrow transplantation in leukaemia patients treated with methotrexate-containing GVHD prophylaxis: a single-centre experience Anticancer Research 17(1b): 589-599
Potolicchio, I.; Brookes, P.A.; Madrigal, A.; Lechler, R.I.; Sorrentino, R. 1996: HLA-DPB1 mismatch at position 69 is associated with high helper T lymphocyte precursor frequencies in unrelated bone marrow transplant pairs Transplantation 62(9): 1347-1352
Blaise, D.; Guyotat, D.; Reiffers, J.; Olive, D.; Michallet, M.; Bellanger, C.; Vernant, J.P.; Ifrah, N.; Attal, M.; Vilmer, E. 1991: Prospective randomized study of GVHD prevention using an anti IL2 receptor (CD25) MoAb after allogeneic bone marrow transplantation (BMT) Bone Marrow Transplantation 7 Suppl. 2: 150
Cooper, M.H.; Maraninchi, D.; Gastaut, J.A.; Mannoni, P.; Carcassonne, Y. 1993: HIV infection in autologous and allogeneic bone marrow transplant patients: a retrospective analysis of the Marseille bone marrow transplant population Journal of Acquired Immune Deficiency Syndromes 6(3): 277-284
Oudshoorn, M.; Falkenburg, J.H.; Ebeling, L.J.; Haak, H.L.; Wijermans, P.W.; Fibbe, W.E.; Willemze, R.; van Rood, J.J. 1996: Unrelated bone marrow transplantation as a rescue procedure following inadvertent loss of an autologous bone marrow graft Bone Marrow Transplantation 18(2): 461-463
Suttorp, M.; Schmitz, N.; Prange, E.; Oster, W.; Löffler, H.; Schaub, J.; Ganser, A. 1991: Remission of juvenile chronic myeloid leukemia following graft failure of an unrelated marrow transplant and autologous recovery of marrow function promoted by GM-CSF and IL-3 Leukemia 5(8): 723-725
Bai, Y. 1989: Monoclonal antibody in the detection of neuroblastoma cells in bone marrow aspirates Zhonghua Zhong Liu Za Zhi 11(4): 260-262
Alonso, K.; Medenica, R.; Morehead, G. 1994: Long-term culture of autologous bone marrow for marrow reconstitution following high-dose chemotherapy. Purging with tumor surface antigen directed human-human monoclonal antibody Progress in Clinical and Biological Research 389: 111-118
Combaret, V.; Kremens, B.; Favrot, M.C.; Laurent, J.C.; Philip, T. 1988: S-L 11.14: a monoclonal antibody recognizing neuroectodermal tumors with possible value for bone marrow purging before autograft Bone Marrow Transplantation 3(3): 221-227
Giai, M.; Natoli, C.; Sismondi, P.; Biglia, N.; Lesti, G.; Mulieri, M.; Iacobelli, S. 1990: Bone marrow micrometastases detected by a monoclonal antibody in patients with breast cancer Anticancer Research 10(1): 119-121
Ringdén, O.; Labopin, M.; Gluckman, E.; Reiffers, J.; Vernant, J.P.; Jouet, J.P.; Harrousseau, J.L.; Fiere, D.; Bacigalupo, A.; Frassoni, F.; Gorin, N.C. 1996: Graft-versus-leukemia effect in allogeneic marrow transplant recipients with acute leukemia is maintained using cyclosporin a combined with methotrexate as prophylaxis. Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation Bone Marrow Transplantation 18(5): 921-929
Gorski, J.; Yassai, M.; Keever, C.; Flomenberg, N. 1995: Analysis of reconstituting T cell receptor repertoires in bone marrow transplant recipients Archivum Immunologiae et Therapiae Experimentalis 43(2): 93-97
Berthold, F.; Schumacher, R.; Schneider, A.; Bosslet, K.; Reiter, C. 1989: Removal of neuroblastoma cells from bone marrow by a direct monoclonal antibody rosetting technique Bone Marrow Transplantation 4(3): 273-278
Tollemar, J.; Ringdén, O.; Andersson, S.; Sundberg, B.; Ljungman, P.; Tydén, G. 1993: Randomized double-blind study of liposomal amphotericin B (Ambisome) prophylaxis of invasive fungal infections in bone marrow transplant recipients Bone Marrow Transplantation 12(6): 577-582
Rowlings, P.A.; Horowitz, M.M.; Armitage, J.O.; Gale, R.P.; Sobocinski, K.A.; Zhang, M.J.; Bortin, M.M. 1993: Report from the International Bone Marrow Transplant Registry and the North American Autologous Bone Marrow Transplant Registry Clinical transplants 1993: 101-108
Dreger, P.; Viehmann, K.; Steinmann, J.; Schmitz, N.; Suttorp, M.; Eckstein, V.; Löffler, H.; Müller-Ruchholtz, W. 1993: CD48 monoclonal antibody K31 for bone marrow transplantation: T-depleting capacity and influence on hematopoietic progenitors Bone Marrow Transplantation 12(Suppl 3): S13-S17